Ind-Swift Limited (INDSWFTLTD.NS)
INR 13.29
(2.0%)
INR 13.29
(2.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 10.13 Billion INR | 2.15% |
| 2022 | 9.92 Billion INR | -2.84% |
| 2021 | 10.21 Billion INR | 1.3% |
| 2020 | 10.08 Billion INR | 0.57% |
| 2019 | 10.02 Billion INR | 0.71% |
| 2018 | 9.95 Billion INR | -4.36% |
| 2017 | 10.41 Billion INR | -0.68% |
| 2016 | 10.48 Billion INR | 0.15% |
| 2015 | 10.46 Billion INR | 14.97% |
| 2014 | 9.1 Billion INR | -2.33% |
| 2013 | 9.32 Billion INR | -1.13% |
| 2012 | 9.42 Billion INR | 245.87% |
| 2011 | 2.72 Billion INR | -54.48% |
| 2010 | 5.98 Billion INR | 15.38% |
| 2009 | 5.18 Billion INR | 34.52% |
| 2008 | 3.85 Billion INR | -1.56% |
| 2007 | 3.91 Billion INR | 29.64% |
| 2006 | 3.02 Billion INR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 FY | 10.13 Billion INR | 2.15% |
| 2023 Q4 | 10.13 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q2 | 9.75 Billion INR | 0.0% |
| 2022 Q2 | 10.29 Billion INR | 0.0% |
| 2022 Q4 | 9.92 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 FY | 9.92 Billion INR | -2.84% |
| 2022 Q1 | - INR | -100.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 FY | 10.21 Billion INR | 1.3% |
| 2021 Q4 | 10.21 Billion INR | 0.0% |
| 2021 Q2 | 9.96 Billion INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q4 | 10.08 Billion INR | 0.0% |
| 2020 FY | 10.08 Billion INR | 0.57% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q2 | 10.27 Billion INR | 0.0% |
| 2019 FY | 10.02 Billion INR | 0.71% |
| 2019 Q2 | 10.02 Billion INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q4 | 10.02 Billion INR | 0.0% |
| 2018 Q4 | 9.95 Billion INR | 0.0% |
| 2018 FY | 9.95 Billion INR | -4.36% |
| 2018 Q1 | - INR | -100.0% |
| 2017 FY | 10.41 Billion INR | -0.68% |
| 2017 Q4 | 10.41 Billion INR | 0.0% |
| 2016 Q1 | - INR | -100.0% |
| 2016 Q4 | 10.48 Billion INR | 0.0% |
| 2016 FY | 10.48 Billion INR | 0.15% |
| 2016 Q3 | - INR | -100.0% |
| 2016 Q2 | 10.49 Billion INR | 0.0% |
| 2015 Q2 | 8.62 Billion INR | 0.0% |
| 2015 Q1 | - INR | -100.0% |
| 2015 Q3 | - INR | -100.0% |
| 2015 Q4 | 10.46 Billion INR | 0.0% |
| 2015 FY | 10.46 Billion INR | 14.97% |
| 2014 Q3 | - INR | -100.0% |
| 2014 FY | 9.1 Billion INR | -2.33% |
| 2014 Q1 | - INR | -100.0% |
| 2014 Q4 | 9.1 Billion INR | 0.0% |
| 2014 Q2 | 9.37 Billion INR | 0.0% |
| 2013 Q1 | - INR | -100.0% |
| 2013 Q4 | 9.32 Billion INR | 0.0% |
| 2013 Q3 | - INR | -100.0% |
| 2013 Q2 | 9.55 Billion INR | 0.0% |
| 2013 FY | 9.32 Billion INR | -1.13% |
| 2012 Q4 | 9.7 Billion INR | -10.07% |
| 2012 Q3 | 10.79 Billion INR | 0.0% |
| 2012 FY | 9.42 Billion INR | 245.87% |
| 2011 FY | 2.72 Billion INR | -54.48% |
| 2010 FY | 5.98 Billion INR | 15.38% |
| 2009 FY | 5.18 Billion INR | 34.52% |
| 2008 FY | 3.85 Billion INR | -1.56% |
| 2007 FY | 3.91 Billion INR | 29.64% |
| 2006 FY | 3.02 Billion INR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Hester Biosciences Limited | 2.44 Billion INR | -314.929% |
| RPG Life Sciences Limited | - INR | -Infinity% |
| Suven Pharmaceuticals Limited | 649.96 Million INR | -1460.08% |
| Ipca Laboratories Limited | 14.38 Billion INR | 29.503% |
| Aarti Drugs Limited | 5.64 Billion INR | -79.7% |
| Aarti Pharmalabs Limited | 2.85 Billion INR | -255.476% |
| Albert David Limited | 33.24 Million INR | -30403.451% |
| Alembic Limited | 91.5 Million INR | -10981.92% |
| Alkem Laboratories Limited | 14.18 Billion INR | 28.512% |
| Alembic Pharmaceuticals Limited | 5.13 Billion INR | -97.598% |
| Bafna Pharmaceuticals Limited | 243.89 Million INR | -4057.543% |
| Bajaj HealthCare Limited | 3.32 Billion INR | -204.664% |
| Biofil Chemicals and Pharmaceuticals Limited | 4.38 Million INR | -230931.146% |
| Brooks Laboratories Limited | 56.41 Million INR | -17872.593% |
| Eris Lifesciences Limited | 27.81 Billion INR | 63.542% |
| FDC Limited | 205.18 Million INR | -4841.861% |
| Glenmark Life Sciences Limited | 171.48 Million INR | -5813.201% |
| Gufic Biosciences Limited | 3.32 Billion INR | -204.58% |
| Hikal Limited | 8.17 Billion INR | -24.024% |
| Ind-Swift Laboratories Limited | 166.21 Million INR | -6000.47% |
| Innova Captab Limited | 2.45 Billion INR | -313.7% |
| IOL Chemicals and Pharmaceuticals Limited | 327.6 Million INR | -2995.225% |
| Jagsonpal Pharmaceuticals Limited | 89.41 Million INR | -11240.965% |
| Jubilant Pharmova Limited | 36.64 Billion INR | 72.325% |
| Kilitch Drugs (India) Limited | 316.46 Million INR | -3104.132% |
| Laurus Labs Limited | 25.77 Billion INR | 60.658% |
| Lincoln Pharmaceuticals Limited | 10.66 Million INR | -94950.216% |
| Lupin Limited | 29.21 Billion INR | 65.295% |
| Mangalam Drugs & Organics Limited | 984.92 Million INR | -929.516% |
| Medico Remedies Limited | 80.5 Million INR | -12495.594% |
| Morepen Laboratories Limited | 289.99 Million INR | -3396.633% |
| Nectar Lifesciences Limited | 6.35 Billion INR | -59.55% |
| Orchid Pharma Limited | 1.35 Billion INR | -650.104% |
| Procter & Gamble Health Limited | 95.6 Million INR | -10506.65% |
| Sigachi Industries Limited | 1.43 Billion INR | -608.832% |
| Solara Active Pharma Sciences Limited | 10.11 Billion INR | -0.247% |
| Sun Pharmaceutical Industries Limited | 32.73 Billion INR | 69.026% |
| Themis Medicare Limited | 957.92 Million INR | -958.537% |
| Unichem Laboratories Limited | 2.47 Billion INR | -309.672% |
| Vaishali Pharma Limited | 134.91 Million INR | -7415.644% |
| Venus Remedies Limited | 413.3 Million INR | -2353.413% |
| Wanbury Limited | 1.16 Billion INR | -770.498% |
| Windlas Biotech Limited | 36.41 Million INR | -27749.374% |
| ZIM Laboratories Limited | 1.08 Billion INR | -831.772% |
| Sakar Healthcare Limited | 793.51 Million INR | -1177.852% |
| Aurobindo Pharma Limited | 66.47 Billion INR | 84.747% |
| Divi's Laboratories Limited | 30 Million INR | -33699.857% |
| AstraZeneca Pharma India Limited | 45.98 Million INR | -21952.014% |
| Mankind Pharma Limited | 2.07 Billion INR | -389.445% |
| Sequent Scientific Limited | 4.87 Billion INR | -107.917% |
| Neuland Laboratories Limited | 953.89 Million INR | -963.004% |
| J. B. Chemicals & Pharmaceuticals Limited | 3.77 Billion INR | -168.494% |
| Glenmark Pharmaceuticals Limited | 12.3 Billion INR | 17.624% |
| Zydus Lifesciences Limited | 8.04 Billion INR | -26.088% |
| Amrutanjan Health Care Limited | 17.28 Million INR | -58570.121% |
| Wockhardt Limited | 23.56 Billion INR | 56.961% |
| Bal Pharma Limited | 1.39 Billion INR | -626.106% |
| Dr. Reddy's Laboratories Limited | 20.02 Billion INR | 49.351% |
| Bliss GVS Pharma Limited | 998.4 Million INR | -915.62% |
| Par Drugs and Chemicals Limited | - INR | -Infinity% |
| Caplin Point Laboratories Limited | 19.7 Million INR | -51371.863% |
| Shilpa Medicare Limited | 9.37 Billion INR | -8.172% |
| Valiant Laboratories Limited | 767.08 Million INR | -1221.884% |
| Ajanta Pharma Limited | 352.8 Million INR | -2774.137% |
| Aarey Drugs & Pharmaceuticals Limited | 313.52 Million INR | -3134.198% |
| Granules India Limited | 13.15 Billion INR | 22.894% |
| Medicamen Biotech Limited | 308.17 Million INR | -3190.356% |
| Syncom Formulations (India) Limited | 724.86 Million INR | -1298.873% |
| Piramal Enterprises Limited | 535.85 Billion INR | 98.108% |
| Torrent Pharmaceuticals Limited | 40.22 Billion INR | 74.789% |
| NATCO Pharma Limited | 3.71 Billion INR | -173.167% |
| Suven Life Sciences Limited | 7.09 Million INR | -142776.666% |
| Krebs Biochemicals & Industries Limited | 1.93 Billion INR | -424.22% |
| Strides Pharma Science Limited | 25.16 Billion INR | 59.712% |
| Indoco Remedies Limited | 6.71 Billion INR | -50.901% |
| Alpa Laboratories Limited | 52.46 Million INR | -19227.089% |
| Lasa Supergenerics Limited | 220.76 Million INR | -4493.162% |
| Sun Pharma Advanced Research Company Limited | 611.5 Million INR | -1558.21% |